COPD is an obstructive lung disease. The name itself contains the answer: chronic obstructive pulmonary disease. It is defined by airflow limitation during exhalation, meaning air has trouble getting out of the lungs rather than trouble getting in. This distinction matters because it shapes everything from how the disease is diagnosed to how it feels day to day.
What Makes a Disease “Obstructive”
Lung diseases fall into two broad categories based on how they interfere with breathing. Obstructive diseases make it hard to push air out. Restrictive diseases make it hard to fully expand the lungs and pull air in.
In obstructive disease, the airways narrow or become blocked, so exhaling takes longer and requires more effort. You can think of it like trying to blow air through a pinched straw. The lungs fill reasonably well, but emptying them is the problem. COPD, asthma, and bronchiectasis all fall into this category.
Restrictive diseases work differently. The lungs themselves become stiff, scarred, or physically compressed, so they can’t expand fully on the inhale. Conditions like pulmonary fibrosis, severe scoliosis, and certain neuromuscular diseases cause this pattern. People with restrictive disease tend to take rapid, shallow breaths because their lungs simply can’t hold as much air as they should.
Why COPD Traps Air Inside the Lungs
COPD causes airflow limitation through two overlapping mechanisms. The first is airway dysfunction: chronic inflammation leads to swelling of the airway lining, excess mucus production, airway remodeling, and sometimes muscle spasm. All of this narrows the tubes that air flows through.
The second mechanism is emphysema, which destroys the tiny air sacs (alveoli) and the connective tissue that supports the small airways. Healthy lung tissue has natural elastic recoil, like a stretched rubber band snapping back. Emphysema weakens that recoil, reducing the driving pressure that normally pushes air out. At the same time, the loss of surrounding tissue means the small airways lack structural support and tend to collapse during exhalation, further blocking airflow.
The combination of narrowed airways and reduced elastic recoil creates a signature problem called air trapping. The lungs can’t fully empty before the next breath begins, so stale air accumulates. Over time, this leads to hyperinflation, where the lungs settle at a larger resting volume than normal. That trapped air takes up space, making it harder to draw in a fresh breath and contributing to the persistent breathlessness that defines advanced COPD.
How Spirometry Confirms the Obstruction
The standard test for classifying lung disease is spirometry, where you take the deepest breath possible and then blow out as hard and fast as you can. Two key measurements come from this test: how much air you can force out in the first second (FEV1) and the total amount you can exhale (FVC).
The ratio between these two numbers is what separates obstructive from restrictive patterns. In obstructive disease, the ratio of FEV1 to FVC drops below 0.7, meaning less than 70% of the total air comes out in that critical first second. The rest trickles out slowly through narrowed or collapsing airways. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines require this ratio to remain below 0.7 even after using a bronchodilator inhaler to confirm the diagnosis. Unlike asthma, where the obstruction often reverses with medication, the airflow limitation in COPD is persistent.
In restrictive disease, the pattern looks different on spirometry. Both FEV1 and FVC are reduced, but the ratio between them stays normal or even increases. The lungs are small but the airways are clear, so whatever air is available comes out at a normal rate. Total lung capacity, measured with more advanced testing, falls below normal, confirming that the lungs simply can’t hold enough air.
How This Affects What You Feel
The obstructive nature of COPD produces a specific set of daily experiences. Exhaling feels like it takes extra time and effort, especially during physical activity. Wheezing is common because air is being forced through narrowed passages. Many people describe a sensation of not being able to fully empty their lungs before needing to breathe in again, which creates a feeling of tightness or air hunger that worsens with exertion.
Coughing and mucus production are frequent, particularly in the morning, because inflamed airways generate excess mucus that’s difficult to clear. As hyperinflation progresses, the diaphragm gets pushed downward and flattened by the over-expanded lungs, making it mechanically less efficient. This is one reason why breathlessness in COPD tends to worsen gradually over years: the respiratory muscles are working harder but accomplishing less with each breath.
When COPD Overlaps With Restriction
While COPD is fundamentally obstructive, some people develop a mixed pattern where both obstruction and restriction are present. This happens when COPD coexists with a separate condition that limits lung expansion. Obesity can compress the lungs from the outside. Pulmonary fibrosis can stiffen the lung tissue. Severe kyphosis (curvature of the upper spine) can physically restrict chest wall movement.
In these mixed cases, spirometry results can be tricky to interpret. The drop in FVC from the restrictive component can make the FEV1/FVC ratio look closer to normal than it actually is, potentially masking the severity of obstruction. Conversely, the low FEV1 caused by obstruction can overestimate how much restriction is present. Doctors typically use full pulmonary function testing, including total lung capacity measurements, to sort out what’s happening when both patterns appear together.
Having a mixed pattern doesn’t change COPD’s underlying classification. The obstructive component remains the core feature of the disease. The restrictive component is a separate, coexisting problem that adds to the overall breathing impairment.
Why the Classification Matters for Treatment
Knowing that COPD is obstructive directly shapes how it’s managed. Treatments focus on opening the airways, reducing inflammation inside them, and helping the lungs empty more effectively. Bronchodilator inhalers relax airway muscles to widen the passages. Pulmonary rehabilitation teaches breathing techniques like pursed-lip breathing, which creates back-pressure to keep the small airways open longer during exhalation and reduce air trapping.
Restrictive diseases require a fundamentally different approach because the problem isn’t blocked airways but stiff or compressed lungs. Treatments in that category focus on reducing scarring, supporting chest wall mechanics, or in severe cases, supplementing breathing with mechanical assistance. Applying restrictive-disease strategies to COPD, or vice versa, would miss the underlying problem entirely. The obstructive classification isn’t just an academic label. It’s the reason your treatment plan looks the way it does.